Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics

References

• Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A. 2002. Preparation, characterization and biodistribution of ultrafine chitosan nanoparticles. Int J Pharm. 243:93–105.
   PubMed Web of Science ®Google Scholar
• Bareford LM, Swaan PW. 2007. Endocytic mechanisms for targeted drug delivery. Adv Drug Deliv Rev. 59:748–758.
   PubMed Web of Science ®Google Scholar
• Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. 2014. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 66:2–25.
   PubMed Web of Science ®Google Scholar
• Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, et al. 2015. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Colloids Surf B Biointerfaces 138:1–9.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang L, Lai H, Lu C, Fang M, Zhang Q, Luo X. 2014. Methotrexate-loaded PEGylated chitosan nanoparticles: synthesis, characterization, and in vitro and in vivo antitumoral activity. Mol Pharm. 11:2213–2223.
   PubMed Web of Science ®Google Scholar
• Cho YW, Park SA, Han TH, Son DH, Park JS, Oh SJ, et al. 2007. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials 28:1236–1247.
   PubMed Web of Science ®Google Scholar
• Fruh M, Gillessen S, Cerny T, Demmer R, D'Addario G. 2008. Two-weekly gemcitabine fixed dose rate and oxaliplatin combination chemotherapy for advanced non-small-cell lung cancer. Lung Cancer 62:344–350.
   PubMed Web of Science ®Google Scholar
• Fukuda MN, Ohyama C, Lowitz K, Matsuo O, Pasqualini R, Ruoslahti E, Fukuda M. 2000. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res. 60:450–456.
   PubMed Web of Science ®Google Scholar
• Garg NK, Dwivedi P, Campbell C, Tyagi RK. 2012. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention. Eur J Pharm Sci. 47:1006–1014.
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. 1994. Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603.
   PubMed Web of Science ®Google Scholar
• Hsu C, Kuo SH, Hu FC, Cheng AL, Shih JY, Yu CJ, et al. 2008. Gemcitabine plus conventional-dose epirubicin versus gemcitabine plus cisplatin as first-line chemotherapy for stage IIIB/IV non-small cell lung carcinoma-a randomized phase II trial. Lung Cancer 62:334–343.
   PubMed Web of Science ®Google Scholar
• Jain A, Agarwal A, Majumder S, Lariya N, Khaya A, Agrawal H, Majumdar S, Agrawal GP. 2010. Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release 148:359–367.
   PubMed Web of Science ®Google Scholar
• Jain A, Jain A, Garg NK, Tyagi RK, Singh B, Katare OP, Webstere TJ, Soni V. 2015. Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer. ActaBiomater 24:140–151.
   Google Scholar
• Jain A, Kesharwani P, Garg NK, Jain A, Jain SA, Jain AK, et al. 2015. Galactose engineered solid lipid nanoparticles for targeted delivery of doxorubicin. Colloids and Surf B: Biointerfaces 134:027
   Web of Science ®Google Scholar
• Jain S, Mathur R, Das M, Swarnakar NK, Mishra AK. 2011. Synthesis, pharmacoscintigraphic evaluation and antitumor efficacy of methotrexate-loaded, folate-conjugated, stealth albumin nanoparticles. Nanomedicine 6:1733–1754.
   PubMed Web of Science ®Google Scholar
• Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ. 2004. Cancer statistics, 2004. CA Cancer J Clin. 54:8–29.
   PubMed Web of Science ®Google Scholar
• Ji J, Zuo P, Wang YL. 2015. Enhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticles. Nanoscale 10:453.
   Web of Science ®Google Scholar
• Kerr KM. 2001. Pulmonary preinvasive neoplasia. J Clin Pathol. 54:257–271.
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Iyer AK. 2015. Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery. Drug Discov Today 20:536–547.
   PubMed Web of Science ®Google Scholar
• Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. 2002. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm. 249:165–174.
   PubMed Web of Science ®Google Scholar
• Koo OM, Rubinstein I, Onyuksel H. 2005. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 1:193–212.
   PubMed Web of Science ®Google Scholar
• Kumar G, Sharma S, Shafiq N, Khuller GK, Malhotra S. 2012. Optimization, in vitro-in vivo evaluation, and short-term tolerability of novel levofloxacin-loaded PLGA nanoparticle formulation. J Pharm Sci. 101:2165–2176.
   PubMed Web of Science ®Google Scholar
• Lee KD, Choi SH, Kim DH, Lee HY, Choi KC.2015. Self-organized nanoparticles based on chitosan–folic acid and dextran succinate-doxorubicin conjugates for drug targeting. Arch Pharm Res. 37:1546–1553.
   Web of Science ®Google Scholar
• Mitra S, Gaur U, Ghosh PC, Maitra AN. 2001. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J Control Release 74:317–323.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev. 53:283–318.
   PubMed Web of Science ®Google Scholar
• Na K, Bum Lee T, Park KH, Shin EK, Lee YB, Choi HK. 2003. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur J Pharm Sci. 18:165–173.
   PubMed Web of Science ®Google Scholar
• Nandini PT, Doijad RC, Shivakumar HN, Dandagi PM. 2015. Formulation and evaluation of gemcitabine-loaded solid lipid nanoparticles. Drug Deliv. 22:647–651.
   PubMed Web of Science ®Google Scholar
• O'Shannessy DJ, Yu G, Smale R, Fu YS, Singhal S, Thiel RP, Somers EB, Vachani A. 2012. Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance. Oncotarget 3:414–425.
   PubMed Web of Science ®Google Scholar
• Rampino A, Borgogna M, Blasi P, Bellich B, Cesaro A. 2013. Chitosan nanoparticles: preparation, size evolution and stability. Int J Pharm. 455:219–228.
   PubMed Web of Science ®Google Scholar
• Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, et al. 2000. Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol. 18:122–130.
   PubMed Web of Science ®Google Scholar
• Singh R, Shakya AK, Naik R, Shalan N. 2015. Stability-indicating HPLC determination of gemcitabine in pharmaceutical formulations. Int J Anal Chem. 2015: Article ID: 862592. doi:10.1155/2015/862592.
   PubMed Web of Science ®Google Scholar
• Tseng CL, Wang TW, Dong GC, Yueh-Hsiu WS, Young TH, Shieh MJ, Lou PJ, Lin FH. 2007. Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting. Biomaterials 28:3996–4005.
   PubMed Web of Science ®Google Scholar
• Wang M, Hu H, Sun Y, Qiu L, Zhang J, Guan G, et al. 2013. A pH-sensitive gene delivery system based on folic acid-PEG-chitosan – PAMAM-plasmid DNA complexes for cancer cell targeting. Biomaterials 34:10120–10132.
   PubMed Web of Science ®Google Scholar
• Wilson B, Samanta MK, Santhi K, Kumar KP, Ramasamy M, Suresh B. 2010. Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine. Nanomedicine 6:144–152.
   PubMed Web of Science ®Google Scholar
• Yu X, Yang G, Shi Y, Su C, Liu M, Feng B, Zhao L. 2015. Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance. Int J Nanomed. 10:7045–7056.
   PubMed Web of Science ®Google Scholar
• Zhang BF, Xing L, Cui PF, Wang FZ, Xie RL, Zhang JL, et al. 2015. Mitochondria apoptosis pathway synergistically activated by hierarchical targeted nanoparticles co-delivering siRNA and lonidamine. Biomaterials 61:178–189.
   PubMed Web of Science ®Google Scholar
• Zwicke GL, Mansoori GA, Jeffery CJ. 2012. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev. 3:1–11.
   Google Scholar